Codes / ICD10CM / R87.61

R87.61 Abnormal cytological findings in specimens from cervix uteri

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Abnormal cytological findings in specimens from cervix uteri

Summary

This code represents abnormal cellular changes detected in cervical specimens, such as those from a Pap smear or biopsy. These findings may indicate inflammation, infection, or precancerous changes, but do not specify the exact nature of the abnormality. Further evaluation is often required to determine the underlying cause and appropriate management.

Causes

Abnormal cervical cytology can result from various factors, including human papillomavirus (HPV) infection, inflammation, hormonal changes, or physical irritation. Infections like bacterial vaginosis or yeast infections may also contribute to cellular changes. The exact cause depends on the specific cytological findings.

Risk Factors

  • Risk factors include persistent HPV infection, multiple sexual partners, early sexual activity, smoking, a weakened immune system, and a history of cervical abnormalities. Age and lack of regular cervical screening may also increase risk.

Symptoms

  • Abnormal cervical cytology typically does not cause symptoms. It is usually identified during routine cervical cancer screening. Symptoms, if present, may relate to underlying conditions like infection or inflammation, such as abnormal discharge or bleeding.

Diagnosis

Diagnosis is made through cervical cytology (e.g., Pap smear) or histological examination of cervical tissue. If abnormal findings are detected, follow-up may include HPV testing, colposcopy, or biopsy to assess the severity and guide management.

Treatment Options

  • Treatment depends on the underlying cause and severity of the findings. For mild abnormalities, observation with repeat testing may be sufficient. If HPV or precancerous changes are present, options may include monitoring, treatment of infections, or procedures like cryotherapy or loop electrosurgical excision procedure (LEEP) for higher-grade lesions.

Prognosis and Follow-Up

Prognosis varies based on the cause and severity of the cytological changes. Many mild abnormalities resolve spontaneously, especially if related to transient infections. Regular follow-up with cervical screening is essential to monitor for progression or recurrence.

Complications

  • Untreated or progressive abnormalities may lead to cervical dysplasia or cancer. Chronic inflammation or persistent HPV infection increases this risk. Early detection and management reduce complications.

Lifestyle & Prevention

  • Practice safe sex to reduce HPV exposure. Avoid smoking, as it increases cervical cancer risk. Maintain regular cervical screenings as recommended by guidelines. A healthy immune system supports natural resolution of mild abnormalities.

When to Seek Professional Help

  • Seek care if you experience abnormal bleeding, discharge, or pain, or if you have not had a recent cervical screening. Follow up promptly with abnormal cytology results to determine next steps.

Tips for Medical Coders

  • Use this code for documented abnormal cervical cytology findings without a more specific diagnosis. Ensure documentation supports the abnormality and excludes other specified codes. Verify if additional codes (e.g., for HPV or infections) are warranted based on clinical findings.
Book a walkthrough

R87.61 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.